Skip to contentI
iBio, Inc.
I
IBIOiBio, Inc. Q1 2015 · 10-Q
Revenue$819.00K$819.00K— vs Q1 2014 Net Income-$1.41M-$1.41MN/M vs Q1 2014 EPS Diluted-$0.02-$0.02N/M vs Q1 2014 Operating Income-$1,416,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
iBio, Inc. · CIK 1420720 · Engraved from SEC EDGAR
Free Cash Flowderived-$584,000N/M Margins · derivedOperating margin-172.9%
Net margin-172.2%
ended Sep 30, 2014 · filed Nov 14, 2014 · 45 d after period end